FindTrial
Sign In

A study of doxapram to the respiratory depression of propofol on gastroinstestinal endoscopy

A study of doxapram to the respiratory depression of propofol on gastroinstestinal endoscopy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017832
Enrollment
Unknown
Registered
2018-08-16
Start date
2018-08-14
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal disease

Interventions

Group 2:infusion of doxapram
Group 1:saline infusion

Sponsors

Wuxi People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: patients planned to undergoing painless gastrointestinal endoscope with propofol

Exclusion criteria

Exclusion criteria: cardiac disease, hypertension ,pregnancy, drug allergy,abnormal of liver and kidney function of

Design outcomes

Primary

MeasureTime frame
mean arterial pressure;heart rate;saturation of oxygen;respiratory depression;—

Countries

China

Contacts

Public ContactGu Zhengfeng

Wuxi People's Hospital

gzf110677@163.com+86 13861789062

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 1, 2026